Licaminlimab
Oculis Announces Phase 2 Results for Licaminlimab in Dry Eye Disease, Despite Limited Statistical Significance
Oculis, Licaminlimab, Dry Eye Disease, Phase 2 Results, Statistical Significance
Actionable Insights Powered by AI
Oculis, Licaminlimab, Dry Eye Disease, Phase 2 Results, Statistical Significance